Advanced search
Publication Cover
British Journal of Biomedical Science Volume 76, 2019 - Issue 4
Journal homepage
59
Views
4
CrossRef citations to date
0
Altmetric
Biomedical Science in Brief

IL-6 −572G/C and −174G/C polymorphisms association with hepatitis C virus-induced hepatocellular carcinoma

AA BadawyMedical Biochemistry Department, Mansoura University, Mansoura, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4966-3839
ORCID Icon,
G OthmanMedical Biochemistry Department, Mansoura University, Mansoura, Egypt
,
LM ElabbasyMedical Biochemistry Department, Mansoura University, Mansoura, Egypt
,
M Abd ElsalamInternal Medicine Department, Nephrology and Dialysis Unit, Mansoura University, Mansoura, EgyptORCID Iconhttps://orcid.org/0000-0002-4682-2777
ORCID Icon,
R ShriefMedical Microbiology and Immunology Department, Mansoura University, Mansoura, Egypt
,
EM FahmyMedical Microbiology and Immunology Department, Aswan University, Aswan, Egypt
,
NM KamelClinical Pathology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, EgyptORCID Iconhttps://orcid.org/0000-0002-7673-0697
ORCID Icon,
A OsmanClinical Pathology Department, Faculty of Medicine, Aswan University, Aswan, Egypt
&
ME ZakiClinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
 show all
Pages 201-204 | Received 11 Jun 2019, Accepted 08 Jul 2019, Published online: 07 Aug 2019

References

  • Shin S, Kim N, Kim J, et al. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea. World J Gastroenterol. 2015;21:13064–13072.
  • Coussens L, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867.
  • Sghaier I, Mouelhi L, Rabia NA, et al. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients. Cytokine. 2017;89:62–67.
  • Bergmann J, Müller M, Baumann N, et al. IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice. Hepatology. 2017;65:89–103.
  • Lippitz B, Harris R. Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis. Oncoimmunology. 2016;5:e1093722.
  • Liu Y, Fuchs J, Li C, et al. A risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells. Cell Cycle. 2010;9:3423–3427.
  • Tang S, Yuan Y, He Y, et al. Genetic polymorphism of interleukin-6 influences susceptibility to HBV-related hepatocellular carcinoma in a male Chinese Han population. Hum Immunol. 2014;75:297–301.
  • Yi S, Choi J, Yi J, et al. Risk Factors for hepatocellular carcinoma by age, sex, and liver disorder status: a prospective cohort study in Korea. Cancer. 2018;124:2748–2757.
  • Chang L, Lan T, Wu L, et al. The association between three IL-6 polymorphisms and HBV-related liver diseases: a meta-analysis. Int J Clin Exp Med. 2015;8:17036–17045.
  • Liu Y, Gao S, Du B, et al. Association of IL-6 polymorphisms with hepatocellular carcinoma risk: evidences from a meta-analysis. Tumor Biol. 2014;35:3551–3561.
  • Bennermo M, Held C, Stemme S, et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases. Clin Chem. 2004;50:2136–2140.
  • Porta C, De Amici M, Quaglini S, et al. Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. Ann Oncol. 2008;19:353–358.
  • Shakiba E, Ramezani M, Sadeghi M. Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis. Clin Exp Hepatol. 2018;4:182–190.
  • Naugler W, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317:121–124.
  • Othman MS, Aref AM, Mohamed AA, et al. Serum levels of interleukin-6 and Interleukin-10 as biomarkers for hepatocellular carcinoma in Egyptian patients. ISRN Hepatol. 2013;2013:412317.
  • Jerrard-Dunne P, Sitzer M, Risley P, et al. Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke. 2004;35:2438–2444.
  • Mattos MF, Biselli-Chicote PM, Biselli JM, et al. Interleukin 6 and 10 serum levels and genetic polymorphisms in children with down syndrome. Mediators Inflamm. 2018;2018:6539548.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.